Boston Scientific Corp.

Marlborough medical device manufacturer Boston Scientific Corp. announced Monday a clinical trial for its TheraSphere cancer treatment successfully met both of its primary endpoints.

Marlborough-based medical device maker Boston Scientific announced on Tuesday it has entered an agreement to acquire California anti-blood clot technology maker Devoro Medical, Inc. of California.

Marlborough medical device manufacturer Boston Scientific Corp. acquired Lumenis, an Israel-based surgical company specializing in urological lasers, in a $1.1-billion deal announced on Wednesday.

Boston Scientific, a medical device manufacturer based in Marlborough, announced in June that David Wichmann has been elected to its board of directors, effective immediately.

Boston Scientific, a medical device manufacturer based in Marlborough, has announced it will purchase the remaining shares of Farapulse, Inc. for a total purchase amount of up to $575 million.

Boston Scientific, a medical device manufacturer based in Marlborough, has been granted European approval for a single-use bronchoscope, which is a camera inserted into the airway all the way to the lungs.

In Worcester Business Journal's annual list of the most influential people in the Central Massachusetts economy, the Power 50, one-third of those listed have ties to the manufacturing industry.

Boston Scientific reported a first quarter turnaround with profits rising from $11 million in the quarter in 2020 to $327 million this year.

Marlborough medical device company Boston Scientific has released newly obtained study data speaking to the effectiveness of its TheraSphere Y-90 Glass Microspheres cancer treatment.

Marlborough medical device company Boston Scientific has received U.S. Food and Drug Administration approval for its TheraSphere Y-90 Glass Microspheres cancer treatment.